Endometrial cancer in women 45 years of age or younger

European Journal of Gynaecological Oncology

Volumn 21, Issue 3, 2000, Pages 249-250

  Patsner, Bruce ^a  

^a New Jersey Gynecologic Oncology   (United States)

Author keywords

Age 45; CA 125; Endometrial cancer; Younger patient

Indexed keywords

CA 125 ANTIGEN;

ADULT; ARTICLE; CANCER SURVIVAL; ENDOMETRIUM CANCER; FEMALE; HUMAN; MAJOR CLINICAL STUDY; PROGNOSIS;

ADULT; CA-125 ANTIGEN; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; MIDDLE AGED; NEOPLASM STAGING;

EID: 0033926166     PISSN: 03922936     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Landis S. H., Murray T., Bolden S. et al.: "Cancer statistics". CA Cancer J. Clin.. 1998,48, 6.
2. Gallup D., Stock R. J.: "Adenocarcinoma of the endometrium in women 40 years of age or younger". Obstet. Gynecol., 1984, 64, 417.
3. Jeffrey J. D., Taylor R., Robertson D. I., Stuart G. C. S.: "Endometrial carcinoma occurring in patients under the age of 45 years". Am. J. Obstet. Gynecol., 1987, 156, 366.
4. Crissman J. D., Azoury R. S., Barnes A. E., Schellhas H. F.: "Endometrial carcinoma in women 40 years of age or younger". Obstet. Gynecol., 1981, 57, 699.
5. Evans-Metcalf E. R., Brooks S. E., Reale F. R., Baker S. P.: "Profile of women 45 years of age and younger with endometrial cancer". Obstet. Gynecol., 1998, 91, 349.
6. Gitsch G., Hanzal E., Jensen D., Hacker N. F.: "Endometrial cancer in prenicnopausal women 45 years and younger". Obstet. Gynecol., 1995, 85, 504.
7. Kim Y. B., Holschneider C. H., Ghosh K., Nieberg R. K., Montz F. J.: "Progestin alone as primary treatment of endometrial carcinoma in premenopausal women". Cancer, 1997, 79, 320.
8. Randall T. C., Kurman R. J.: "Progestin treatment of atypical hyperplasia and well-differentiated carcinoma of the endometrium in women under age 40". Obstet. Gynecol., 1979, 90, 434.
9. Patsner B., Mann W. J., Cohen H., Locsch M.: "Predictive value of pre-operative serum CA-125 levels in clinically localized and advanced endometrial carcinoma". Am. J. Obstet. Gynec., 1988, 158, 399.
10. Scambia G., Gadducci A., Benedetti-Panici P. et al.: "Combined use of serum CA-125 and CA 15-3 in patients with endometrial carcinoma". Gynecol. Oncol., 1994, 54, 292.
11. Kim S. H., Kim H. D., Song Y. S. et al.: "Detection of deep myometrial invasion in endometrial carcinoma: comparison of transvaginal ultrasound, CT, and MRI". J. Comput. Assist. Tomogr., 1995, 19, 766.